Incannex Healthcare (IXHL) Competitors $0.35 -0.03 (-8.07%) Closing price 04:00 PM EasternExtended Trading$0.35 +0.00 (+0.31%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IXHL vs. CUE, KPTI, INMB, ATNM, ESLA, AADI, RNXT, PDSB, FGEN, and OTLKShould you be buying Incannex Healthcare stock or one of its competitors? The main competitors of Incannex Healthcare include Cue Biopharma (CUE), Karyopharm Therapeutics (KPTI), INmune Bio (INMB), Actinium Pharmaceuticals (ATNM), Estrella Immunopharma (ESLA), Aadi Bioscience (AADI), RenovoRx (RNXT), PDS Biotechnology (PDSB), FibroGen (FGEN), and Oncobiologics (OTLK). These companies are all part of the "pharmaceutical products" industry. Incannex Healthcare vs. Its Competitors Cue Biopharma Karyopharm Therapeutics INmune Bio Actinium Pharmaceuticals Estrella Immunopharma Aadi Bioscience RenovoRx PDS Biotechnology FibroGen Oncobiologics Incannex Healthcare (NASDAQ:IXHL) and Cue Biopharma (NASDAQ:CUE) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, risk, earnings, media sentiment and dividends. Which has more risk and volatility, IXHL or CUE? Incannex Healthcare has a beta of 7.5, indicating that its stock price is 650% more volatile than the S&P 500. Comparatively, Cue Biopharma has a beta of 1.55, indicating that its stock price is 55% more volatile than the S&P 500. Does the media favor IXHL or CUE? In the previous week, Cue Biopharma had 2 more articles in the media than Incannex Healthcare. MarketBeat recorded 2 mentions for Cue Biopharma and 0 mentions for Incannex Healthcare. Cue Biopharma's average media sentiment score of 0.95 beat Incannex Healthcare's score of 0.83 indicating that Cue Biopharma is being referred to more favorably in the news media. Company Overall Sentiment Incannex Healthcare Positive Cue Biopharma Positive Do institutionals and insiders hold more shares of IXHL or CUE? 0.4% of Incannex Healthcare shares are held by institutional investors. Comparatively, 35.0% of Cue Biopharma shares are held by institutional investors. 15.5% of Incannex Healthcare shares are held by company insiders. Comparatively, 10.8% of Cue Biopharma shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Is IXHL or CUE more profitable? Incannex Healthcare has a net margin of 0.00% compared to Cue Biopharma's net margin of -469.35%. Cue Biopharma's return on equity of -230.13% beat Incannex Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Incannex HealthcareN/A -671.36% -298.35% Cue Biopharma -469.35%-230.13%-111.16% Which has higher valuation and earnings, IXHL or CUE? Cue Biopharma has higher revenue and earnings than Incannex Healthcare. Cue Biopharma is trading at a lower price-to-earnings ratio than Incannex Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIncannex Healthcare$90K1,351.82-$46.88M-$1.21-0.29Cue Biopharma$9.29M6.54-$40.67M-$0.56-1.41 Do analysts recommend IXHL or CUE? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Incannex Healthcare 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Cue Biopharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SummaryCue Biopharma beats Incannex Healthcare on 8 of the 13 factors compared between the two stocks. Get Incannex Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for IXHL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IXHL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IXHL vs. The Competition Export to ExcelMetricIncannex HealthcareMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$132.34M$2.64B$6.10B$10.55BDividend YieldN/A57.78%5.73%4.78%P/E Ratio-0.294.9863.4322.98Price / Sales1,351.82774.25604.86133.16Price / CashN/A175.9337.8662.13Price / Book5.005.4112.396.65Net Income-$46.88M$33.06M$3.32B$276.79M7 Day Performance-16.65%-2.27%-0.24%-1.51%1 Month Performance-35.18%11.49%9.56%5.45%1 Year Performance-81.49%-3.25%71.67%36.24% Incannex Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IXHLIncannex Healthcare0.8075 of 5 stars$0.35-8.1%N/A-78.7%$132.34M$90K-0.293CUECue Biopharma2.6915 of 5 stars$0.73+1.5%N/A-29.9%$56.03M$9.29M-1.3060Analyst ForecastKPTIKaryopharm Therapeutics4.1904 of 5 stars$6.38+1.4%$34.00+432.9%-52.6%$55.32M$145.24M-0.44380Trending NewsAnalyst UpgradeAnalyst RevisionGap UpINMBINmune Bio2.1078 of 5 stars$2.08-2.8%$18.50+789.4%-60.0%$55.29M$10K-0.8410ATNMActinium Pharmaceuticals2.1535 of 5 stars$1.58-1.3%$4.50+184.8%-11.7%$49.29MN/A-1.1430ESLAEstrella Immunopharma2.6549 of 5 stars$1.31-0.8%$16.00+1,121.4%+108.6%$48.56MN/A-5.04N/AShort Interest ↓AADIAadi BioscienceN/A$1.96+1.0%N/A-7.5%$48.41M$25.07M-0.8640RNXTRenovoRx2.4206 of 5 stars$1.32+3.9%$7.50+468.2%+30.3%$48.37M$662K-3.476Short Interest ↓PDSBPDS Biotechnology1.747 of 5 stars$1.02flat$10.00+880.4%-69.7%$47.97MN/A-1.1120FGENFibroGen4.1462 of 5 stars$11.73-1.7%$43.00+266.6%+24.6%$47.39M$29.62M-30.87570OTLKOncobiologics2.8111 of 5 stars$1.06-0.9%$7.00+560.4%-71.5%$47.09MN/A-1.8620 Related Companies and Tools Related Companies Cue Biopharma Alternatives Karyopharm Therapeutics Alternatives INmune Bio Alternatives Actinium Pharmaceuticals Alternatives Estrella Immunopharma Alternatives Aadi Bioscience Alternatives RenovoRx Alternatives PDS Biotechnology Alternatives FibroGen Alternatives Oncobiologics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IXHL) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersBuy alert: Move $1,000 before Tesla’s Optimus launchElon's $1,000,000,000,000 payday Elon Musk just made his biggest insider purchase of Tesla stock ever. He's...Altimetry | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredWall St’s “AI Godfather” breaks his silenceWhats next after AI? Hidden AI. "Hidden AI" could soon be the biggest investment trend of 2025.Chaikin Analytics | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Incannex Healthcare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Incannex Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
